Figure 2.
SARS-CoV-2 replication rate in the lungs of control (A) and Riamilovir (B) groups: (A) saline, 20 mL/kg, intraperitoneal, daily from 3 to 7 days after infection; (B) Riamilovir, 20 mg/kg, intraperitoneal, daily from 3 to 7 days after infection. Reprinted/adapted with permission (CC BY 3.0) from Ref. [76]. 2021, Chepur S.V. et al.
